Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.
Emergent recruits NFL Hall of Famer for Narcan opioid overdose campaign
Emergent BioSolutions is taking its opioid overdose campaign to college football tailgates. The Maryland-based company is showing up at tailgate parties across the country with